- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | 1 | GlobeNewswire (USA) | ||
| Mi | Kaplan Fox Encourages Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) to Contact the Firm Regarding Potential Securities Law Violations | 1 | Barchart.com | ||
| 08.09. | Alignment Healthcare USA, LLC: Alignment Health Plan and Hoag Health System Increase Access to Award-Winning Care for Orange County Seniors | 3 | GlobeNewswire (USA) | ||
| 18.08. | Alignment Healthcare files motion to dismiss whistleblower lawsuit | 2 | Seeking Alpha | ||
| 07.08. | Can ALHC's Raised 2026 Outlook Offset Heavier Second-Half Spending? | 3 | Zacks | ||
| 03.08. | Sorgen um Gewinnentwicklung: Raymond James stuft Alignment Healthcare ab | 2 | Investing.com Deutsch | ||
| 03.08. | Raymond James downgrades Alignment Healthcare stock rating on earnings visibility concerns | 2 | Investing.com | ||
| ALIGNMENT HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 31.07. | Alignment Healthcare boasts 32% revenue jump in Q2, lifts 2026 outlook | 1 | FierceHealthcare | ||
| 31.07. | Alignment Healthcare forecasts $5.20B-$5.23B 2026 revenue while raising membership outlook to 298k-301k | 8 | Seeking Alpha | ||
| 30.07. | Alignment Healthcare, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 30.07. | Alignment Healthcare Turns Profit As Insurer Gets Handle On Costs | 1 | Forbes | ||
| 30.07. | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | 810 | GlobeNewswire (Europe) | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| 30.07. | Alignment Healthcare, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.07. | Reasons to Retain Alignment Healthcare Stock in Your Portfolio for Now | 1 | Zacks | ||
| 10.07. | Kaplan Fox & Kilsheimer LLP: Kaplan Fox Alerts Investors of Alignment Healthcare, Inc. (ALHC) to an Investigation of Potential Securities Law Violations | 1.063 | Newsfile | New York, New York--(Newsfile Corp. - July 10, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or... ► Artikel lesen | |
| 09.07. | Former exec alleges Alignment Healthcare leaders juiced profits to boost bonuses | 1 | FierceHealthcare | ||
| 09.07. | Aktie von Alignment Healthcare erholt sich - Analysten stufen Kursrutsch als überzogen ein | 4 | Investing.com Deutsch | ||
| 09.07. | Analystenkommentar stützt Alignment Healthcare Aktie nach Kurssturz | 1 | Investing.com Deutsch | ||
| 09.07. | KeyBanc reiterates Alignment Healthcare stock rating after lawsuit | 1 | Investing.com | ||
| 09.07. | Alignment Healthcare plunges on whistleblower lawsuit report | 2 | Seeking Alpha |
1 2 3 Weiter >>
50 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,630 | +0,11 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| HIMS & HERS HEALTH | 24,940 | 0,00 % | HIMS Bulls Should Heed This Historic Chart Signal | ||
| SERNOVA BIOTHERAPEUTICS | 0,099 | +48,20 % | Dr. Steven S. Sangha: Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc. | Toronto, Ontario--(Newsfile Corp. - September 11, 2026) - Steven Sangha announces he has entered into a voting and support agreement ("Voting Agreement") with Seraxis Holdings, Inc. ("Seraxis") in connection... ► Artikel lesen | |
| CERENOME | 1,898 | -6,04 % | Cerenome, Inc.: Cerenome Announces Up to $20 Million Financing Facility with Royalty-Based Repayment | Capital will support continued CNSide commercial scale-up and development Initial tranche of funding provided at closing with future tranches linked to milestones Forecasted cash runway now into 2028... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,180 | +0,93 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Historischer Wendepunkt - darum fliegt die Aktie! | Volltreffer: Bereits im Frühjahr hatte ich die positive Entwicklung bei Sonoma Pharmaceuticals antizipiert und die Nano-Cap-Aktie als hochinteressante Turnaround-Spekulation vorgestellt. Damals hatte... ► Artikel lesen | |
| TANDEM DIABETES | 14,900 | +2,05 % | Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now | ||
| CO-DIAGNOSTICS | 1,125 | 0,00 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| QUIDELORTHO | 9,338 | -6,26 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,360 | 0,00 % | Veru Inc.: Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines' RASONQUE) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial | ||
| LIFEWARD | 7,110 | +1,57 % | Lifeward Ltd.: Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy | ||
| CLOVER HEALTH INVESTMENTS | 4,300 | -2,49 % | Clover Health Investments, Corp.: Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026 | WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great... ► Artikel lesen | |
| SENSEONICS | 7,450 | -2,61 % | Senseonics sees activist investor take a major stake | ||
| TEMPEST THERAPEUTICS | 0,778 | -0,78 % | Tempest Therapeutics Announces Up to $7.5 Million Private Placement | BRISBANE, Calif., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (the "Company"), a clinical-stage biotechnology company pioneering the development of advanced in vivo... ► Artikel lesen | |
| NANO-X IMAGING | 0,700 | 0,00 % | Nano-X Imaging Ltd: Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica | Agreement with SOLME RC, SA Marks the third Latin American market this year PETACH TIKVA, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (NASDAQ: NNOX) ("Nanox"), a leader in innovative... ► Artikel lesen |
Das Unternehmen ALIGNMENT HEALTHCARE INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 12,935 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ALIGNMENT HEALTHCARE INC finden Sie auf Wallstreet Online.